Study of AXT-1003 in Adult Subjects With Relapsed/Refractory Non-Hodgkin Lymphomas
Clinical trial NCT05965505 · TERMINATED
Trial details
- NCT number
- NCT05965505
- Sponsor
- Axter Therapeutics (Beijing) Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-11
- Primary completion
- 2023-09-05
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.